1- Bremme, K. A., (2003). Haemostatic changes in pregnancy. Best Piact Res Clin Haematol. 16(2) :153-168[
PubMed 12763484].
2- Levey, A.S., Coresh, J., Balk, E., Kausz, A. T., Leven, A.& Steffes, M. W., et al. (2003). National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. No.(139). P:137-47.
3- Gaw, A., Cowan,R. A., O'Reilly DStJ, Stewart, M. J.& Shepherd, J. (1999). Clinical biochemistry-an illustrated color text. 2nd edition. Edinburgh: Churchill Livingstone. P: 140-143.
4- Kawana, T., Murata, T., Kojima, T. & Ayabe T. (2004)., "Management of pregnant women with Toxoplasma IgM antibody". Journal of Japan Society of Prenatal & Neonatal Medicine. Vol. 40. No .3: 523-528.
5- Bacq, Y., Zarka, O.& Brechot, J.-F. et al.(1996). "Liver function tests in normal pregnancy : A prospective study of 103 pregnant women and 103 matched controls. Hepatology. Vol. 23 (5): 1030-1034.[PubMed:8621129].
6- Ganort, PO. (1972). " Variation of the concentration of some plasma proteins in normal adults in pregnant women and in newborns. Scand J. Clin Lab Invest. Vol. 29 (124): 83-88. .[PubMed:4114362].
7- Benster, B.& Wood, E. J., (2010). "BJOG: An International Journal of Obstetrics & Gynaecology" (Immunoglobulin levels in normal pregnancy and pregnancy complicated by hypertension). Vol. 77. No. (6) : 518-522.
8- Hudson, L. & Hay, F. C.. (1989).Practical Immunology. 3rd ed. Blackwell Scientific Publications. Oxford.
9- Chap, T. LE. (2003). "Introductory Biostatistics". John Wily & Sons publications. Canada, NewJersy.
10- Sotil, EU.& Jensen, DM., (2004). Serum enzymes associated with cholestasis. Clin Liver Dis. 8 (1): 41-54. [PubMed: 15062192] .
11- Health- Families.com, LLC,(2011). Pregnancy "Total Serum Protein test".
13- Jerremy, E., Kaslow, M. D.& F.A.C.A.A.I. (2010). "Serum protein". Drkaslow.com. 720 North Tustin Avenue. Santa Ana.
14- Thomas, J., Richard, A.& Barbara, A. (2007). "Kuby Immunology". 6th edition. W.H. Freeman and company: Houndmills, England. P: 95-98.
15- Sacks, G., Sargent, L., &Redman, C.(1999). "An innate view of human pregnancy". Immunol Today. Vol . 20: 114-118.
16- Karen, S., Carola, G.& Gisela, E. (2005). "Parvovirus B19 diagnosis in pregnant women-quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum. Spring Link Journal.. Vol. 25. No. (1):32-34.
17- Adriana, C., Giovanna, P., Simona, P., Chiara, G., Carlo, C. & Giuseppe, D. (2008). "Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM Assays Incorporating the New Vidia Analyzer System". Clin. Vaccine Immunol. 15(7): 1067-1079.
18- Petersen, E., M. V. Borobio, E. Guy, O. Liesenfeld, V. Meroni, A. Naessens, E. Spranzi, and P. Thulliez. (2005). European multicenter study of the LIAISON automated diagnostic system for determination of
Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J. Clin. Microbiol. 43
:1570-1574. [
PMC free article] [
PubMed].
19- Liu, KL., Li N., Li BJ, Peng JY., Shu XW.& Yu YY. (2009)."Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women. U.S. National Library of Medicine National Institutes of Health. Vol. 11(3): 185-187.
20- Montoya, J. G. (2002). Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J. Infect. Dis. 185:S73-S82.
21- Alvarado-Esquivel, C. Sethi, S., Janitschke, K., Hahn, H. & Liesenfeld, O. (2002). Comparsion of two commercially available avidity tests for Toxoplasma specific IgG antibodies. Arch. Med. Res. 33: 520-523. [
PubMed]